1. Executive Summary
1.1 Cardiac Rhythm Management Devices Market Highlights
1.2 Overview of Chapter Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Relating to Cardiac Rhythm Management Devices
2. Introduction
2.1 Cardiac Rhythm Management Definition
2.2 The Heart
2.3 Cardiac Rhythm Disorders
2.3.1 Heart Failure
2.3.2 Arrhythmias
2.3.2.1 Tachycardia
2.3.2.2 Bradycardia
2.4 Cardiac Rhythm Management Devices
2.4.1 Pacemakers
2.4.1.1 History of Pacemakers
2.4.2 Implantable Cardioverter Defibrillators (ICD)
2.4.2.1 History of ICD Devices
2.4.3 Cardiac Resynchronisation Therapy (CRT)
2.4.4 Cardiac Ablation Devices
2.5 Regulation of Cardiac Rhythm Management Devices
2.5.1 The US Regulation System
2.5.2 The European Regulation System
2.5.2.1 Post Marketing Surveillance in the EU
3. The Global Cardiac Rhythm Management Devices Market, 2010-2021
3.1 Cardiac Rhythm Management Devices: Market Overview
3.1.1 The Cardiac Rhythm Management Devices Market in 2010
3.2 Regional Market Breakdown, 2010
3.2.1 The US and Japanese Markets
3.2.2 The European Market
3.2.3 The Chinese and Indian Markets
3.3 Global Cardiac Rhythm Management Devices Market Forecast, 2011-2015
3.4 Global Cardiac Rhythm Management Devices Market Forecast, 2015-2021
3.5 Leading Regional Markets for Cardiac Rhythm Management Devices, 2011-2021
3.5.1 The US, European and Japanese Markets, 2011-2021
3.5.1.1 The US Market
3.5.1.2 The European Markets
3.5.1.3 The Japanese Market
3.5.2 The Chinese and Indian Markets, 2011-2021
3.5.2.1 The Chinese Market
3.5.2.2 The Indian Market
4. The Implantable Cardioverter Defibrillator (ICD) Market, 2010-2021
4.1 Chapter Overview
4.2 Leading Companies in the Defibrillator Market, 2010
4.3 The ICD Market in 2010
4.3.1 Regional Breakdown of the ICD Market
4.3.2 Leading Products in the ICD Market, 2010
4.4 The ICD Market Forecast, 2011-2021
4.4.1 The ICD Market Forecast, 2011-2015
4.4.2 The ICD Market Forecast, 2015-2021
4.5 The ICD Market Pipeline
4.5.1 AnalyST Accel ICD (St. Jude Medical)
4.5.2 Paradym RF (Sorin Group)
4.5.3 PICD- Percutaneous Implantable Cardioverter Defibrillator (InnerPulse)
4.5.4 S-ICD System (Cameron Health)
4.5.5 Other Devices
4.5.6 Remote Monitoring
4.6 SWOT Analysis of the ICD Market, 2011-2021
4.6.1 Strengths
4.6.1.1 ICD Devices are More Effective than Anti-Arrhythmia Drugs
4.6.1.2 Continuous Innovation in the Industry
4.6.2 Weaknesses
4.6.2.1 Safety Concerns Regarding ICD Devices
4.6.2.2 Longevity of Devices
4.6.3 Opportunities
4.6.3.1 Aging Population will Lead to an Increased Patient Base
4.6.3.2 Increasing Use of ICD Devices as Prophylactics
4.6.3.3 Emerging Markets Offer Growth Opportunities
4.6.4 Threats
4.6.4.1 Only a Small Number of Companies Operate in The Largest CRM Devices Market
4.6.4.2 Anti Arrhythmia Drugs May Become More Effective
5. The Pacemaker Market, 2010-2021
5.1 Chapter Overview
5.2 Medtronic Dominates the Pacing Devices Market
5.3 The Pacemaker Market in 2010
5.3.1 Dual-Chamber Pacemakers Dominate the Market in 2010
5.3.2 Regional Breakdown of the Pacemaker Market
5.3.3 Leading Products in the Pacemaker Market
5.4 The Pacemaker Market Forecast, 2011-2021
5.5 The Pacemaker Market Segments, 2010-2021
5.5.1 The Dual-Chamber Pacemaker Market, 2010
5.5.1.1 The Dual-Chamber Pacemaker Market, 2011-2015
5.5.1.2 The Dual-Chamber Pacemaker Market, 2015-2021
5.5.2 The Single Chamber Pacemaker Market, 2010
5.5.2.1 The Single Chamber Pacemaker Market, 2011-2021
5.5.3 The External Pacemaker Market, 2010
5.5.3.1 The External Pacemaker Market, 2011-2021
5.6 The Pacemaker Pipeline
5.6.1 Evia ProMRI Pacemaker Series (BioTronik)
5.6.2 Revo MRI SureScan (Medtronic)
5.6.3 Leadless Pacemakers (Medtronic)
5.6.4 Accent MRI Pacemaker (St. Jude Medical)
5.6.5 SOPHOS 455 (Medico)
5.6.6 Biological Pacemakers (UC Davis)
5.6.7 Stem Cells for the Treatment of Arrhythmias
5.7 SWOT Analysis of the Pacemaker Market, 2011-2021
5.7.1 Strengths
5.7.1.1 Pacemakers are Proven to Save Lives
5.7.1.2 Mature Segment of the Market
5.7.2 Weaknesses
5.7.2.1 Safety Concerns Regarding Pacemakers
5.7.2.2 Longevity of Pacemakers
5.7.3 Opportunities
5.7.3.1 Aging Population Will Increase the Number of Patients Requiring Pacemakers
5.7.3.2 Emerging Economies Will Drive Growth
5.7.4 Threats
5.7.4.1 Only a Small Number of Companies Operate in the Market
5.7.4.2 Biologics and Stem Cells May Become More Important than Artificial Pacemakers
6. The Cardiac Resynchronisation Therapy Devices (CRT) Market, 2010-2021
6.1 Chapter Overview
6.2 The Cardiac Resynchronisation Therapy Market in 2010
6.2.1 Leading Segments in the CRT Market
6.2.2 Leading Products and Companies in the CRT Market
6.3 Cardiac Resynchronisation Therapy Market Forecast, 2011-2021
6.3.1 Cardiac Resynchronisation Therapy Market Forecast, 2011-2015
6.3.2 The Cardiac Resynchronisation Therapy Market Forecast, 2015-2021
6.4 Cardiac Resynchronisation Therapy Pipeline, 2011
6.4.1 Consulta CRT-P (Medtronic)
6.4.2 Optimizer III (Impulse Dynamics)
6.4.3 Unify QUADRA (St. Jude Medical)
6.4.4 SonR System (Sorin Group)
6.5 SWOT Analysis of the Cardiac Resynchronisation Therapy Market, 2011-2021
6.5.1 Strengths
6.5.1.1 CRT has a Broad Range of Indications
6.5.1.2 Combination Products Offer Wider Potential Market
6.5.2 Weaknesses
6.5.2.1 Safety Concerns Surrounding CRT
6.5.2.2 Longevity of Devices
6.5.2.3 Low Awareness of Technology in Emerging Economies
6.5.3 Opportunities
6.5.3.1 Aging Population Will Increase the Target Population for CRT Devices
6.5.3.2 Positive Trial Data Will Help to Stimulate Growth
6.5.4 Threats
6.5.4.1 Drugs May Become More Important Than CRT Devices
7. The Cardiac Ablation Devices Market, 2010-2021
7.1 Chapter Overview
7.2 The Cardiac Ablation Devices Market in 2010
7.2.1 The US was the Largest Market for Cardiac Ablation in 2010
7.2.2 Leading Products in the Cardiac Ablation Market
7.3 Cardiac Ablation Market Forecast, 2011-2021
7.3.1 Cardiac Ablation Market Forecast 2011-2015
7.3.2 The Cardiac Ablation Market Forecast, 2015-2021
7.4 The Cardiac Ablation Pipeline
7.4.1 HeartLight Endoscopic Ablation System (CardioFocus)
7.4.2 The Bard HD Mesh Ablator Catheter (C.R. Bard Electrophysiology)
7.4.3 High Intensity Focused Ultrasound (HIFU) Ablation (ProRhythm)
7.4.4 ATRILAZE Surgical Ablation System (MedicalCV)
7.4.5 Cardiac Ablation Visualisation System (Endosense & Siemens Healthcare)
7.5 SWOT Analysis of the Cardiac Ablation Market
7.5.1 Strengths
7.5.1.1 Current Ablation Therapies are More Effective Than Predecessors
7.5.1.2 Continuous Innovation in the Industry
7.5.1.3 Products Available Now Are Unlikely to Be Market Leaders in Ten Years
7.5.2 Weaknesses
7.5.2.1 Increasing Consolidation in the Market Creating Entry Barriers
7.5.2.2 High Barriers to Entry Threaten to Stifle Innovation
7.5.3 Opportunities
7.5.3.1 Increasing Prevalence of Atrial Fibrillation
7.5.3.2 Emerging Markets Offer Significant Opportunity for Growth
7.5.4 Threats
7.5.4.1 Drugs May Become More Important Than the Ablation Procedure
8. Leading Companies in the Cardiac Rhythm Management Market, 2010
8.1 Boston Scientific
8.1.1 Boston Scientific Sales, 2010
8.1.2 Boston Scientific's Cardiac Rhythm Management Sales, 2010
8.1.3 Boston Scientific Cardiac Rhythm Management Devices Rankings, 2010
8.1.4 Boston Scientific Pipeline
8.2 Medtronic
8.2.1 Medtronic Sales, 2010
8.2.2 Medtronic Cardiac Rhythm Management Sales, 2010
8.2.3 Medtronic Cardiac Rhythm Management Rankings, 2010
8.2.4 Medtronic Pipeline, 2010
8.3 St. Jude Medical
8.3.1 St. Jude Medical Sales, 2010
8.3.2 St. Jude Medical Cardiac Rhythm Management Sales, 2010
8.3.2.1 St. Jude Medical Cardiac Ablation Sales, 2010
8.3.3 St. Jude Medical Cardiac Rhythm Management Rankings, 2010
8.3.4 St. Jude Medical Pipeline
8.4 Other Companies in the Cardiac Rhythm Management Market
9. Expert Opinions
9.1 Dr. Gideon Meiry, Former CTO, Odem Medical
9.1.1 The CRT Market
9.1.2 The Future of the CRT Market
9.1.3 Remote Monitoring
9.2 Dr. Mauro Biffi, Senior Electrophysiologist, University of Bologna
9.2.1 The CRM Market
9.2.2 The Future of the CRM Market
9.2.3 Remote Monitoring
10. Conclusions
10.1 The Cardiac Rhythm Management Devices Market, 2010-2021
10.1.1 Growth Will be Driven by Emerging Markets
10.2 The Implantable Cardioverter Defibrillator Market, 2010-2021
10.3 The Pacemaker Market, 2010-2021
10.4 The Cardiac Resynchronisation Therapy Market, 2010-2021
10.5 The Cardiac Ablation Devices Market, 2010-2021
Appendix A
Appendix B
Visiongain report evaluation form
List of Tables
Table 2.1 The Cardiology Device Market ($bn) by Segment, 2010
Table 2.2 New York Heart Association Functional Classification System
Table 2.3 Common Methods Used to Diagnose CHF
Table 2.4 Management Options for Patients with Heart Failure
Table 2.5 Risk Factors for Developing Arrhythmias
Table 2.6 Treatment Options for Patient Suffering From Arrhythmias
Table 2.7 The Advantages and Disadvantages of Cardiac Resynchronisation Therapy (CRT)
Table 3.1 The Cardiac Rhythm Management Devices Market ($bn) by Segment, 2010
Table 3.2 Leading National Markets for Cardiac Rhythm Management Devices ($bn), 2010
Table 3.3 The Global Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2021
Table 3.4 Leading Cardiac Rhythm Management Devices Regional Market Forecasts ($bn), 2010-2015
Table 3.5 Leading Cardiac Rhythm Management Devices Regional Market Forecasts ($bn), 2015-2021
Table 3.6 Chinese Cardiac Rhythm Management Devices Market: Drivers and Restraints, 2011-2021
Table 4.1 Leading Companies in the Defibrillator Market by Sales ($bn), 2010
Table 4.2 The ICD Market ($bn) by Region/ Country, 2010
Table 4.3 Leading Products in the ICD Market, 2010
Table 4.4 The ICD Market Forecast ($bn), 2010-2015
Table 4.5 The ICD Market Forecast ($bn), 2015-2021
Table 4.6 The ICD Development Pipeline, 2011
Table 4.7 SWOT Analysis of the ICD Market, 2011-2021
Table 5.1 Leading Companies in the Pacing Devices Market by Sales ($bn) and Market Share (%), 2010
Table 5.2 The Pacemaker Market ($bn) by Segment, 2010
Table 5.3 The Pacemaker Market ($bn) by Region/ Country, 2010
Table 5.4 Leading Products in the Pacemaker Market, 2010
Table 5.5 The Pacemaker Market Forecast ($bn), 2010-2021
Table 5.6 The Dual-Chamber Pacemaker Market Forecast ($bn), 2010-2015
Table 5.7 The Dual-Chamber Pacemaker Market Forecast ($bn), 2015-2021
Table 5.8 The Single Chamber Pacemaker Market Forecast ($bn), 2010-2021
Table 5.9 The External Pacemaker Market Forecast ($bn), 2010-2021
Table 5.10 Pacemaker Development Pipeline, 2011
Table 5.11 SWOT Analysis of the Pacemaker Market, 2011-2021
Table 6.1 The Cardiac Resynchronisation Therapy Market ($bn) by Segment, 2010
Table 6.2 Leading Products in the Cardiac Resynchronisation Market, 2010
Table 6.3 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2010-2015
Table 6.4 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2015-2021
Table 6.5 Cardiac Resynchronisation Development Pipeline, 2011
Table 6.6 SWOT Analysis of the Cardiac Resynchronisation Therapy Market, 2011-2021
Table 7.1 The Cardiac Ablation Market ($m) by Region/Country, 2010
Table 7.2 The Leading Products in the Cardiac Ablation Market, 2010
Table 7.3 The Cardiac Ablation Market Forecast ($m), 2010-2015
Table 7.4 The Cardiac Ablation Market Forecast ($m), 2015-2021
Table 7.5 The Cardiac Ablation Pipeline, 2011
Table 7.6 SWOT Analysis of The Cardiac Ablation Market, 2011-2021
Table 8.1 Boston Scientific Sales ($bn) by Business Segment, 2010
Table 8.2 Boston Scientific CRM Segment Sales ($m), 2009 and 2010
Table 8.3 Boston Scientific Rankings by Sales, 2010
Table 8.4 Medtronic Sales ($m) by Business Segment, 2009 and 2010
Table 8.5 Medtronic CRDM Sales ($m), 2010
Table 8.6 Medtronic Sales ($bn) by Region, 2010
Table 8.7 Medtronic Rankings by Sales, 2010
Table 8.8 St. Jude Medical Sales ($m) by Business Segment, 2010
Table 8.9 St. Jude Medical CRM Segment Sales ($m), 2010
Table 8.10 St. Jude Medical Rankings by Sales, 2010
Table 8.11 Other Companies in the Cardiac Rhythm Management Market, 2011
List of Figures
Figure 2.1 Market Shares (%) of the Leading Segments in the Cardiology Device Market, 2010
Figure 2.2 Sales ($bn) of Leading Segments in the Cardiology Device Market, 2010
Figure 2.3 The Exterior of The Human Heart
Figure 2.4 The Interior of The Human Heart
Figure 2.5 The Conducting System of The Human Heart
Figure 2.6 The Timeline of Important Developments in the History of Pacemakers
Figure 3.1 The Cardiac Rhythm Management Devices Market Share (%) by Segment, 2010
Figure 3.2 The Cardiac Rhythm Management Devices Market ($bn) by Segment, 2010
Figure 3.3 Leading National Market Shares (%) in the Cardiac Rhythm Management Devices Market, 2010
Figure 3.4 Leading National Markets ($bn) in the Cardiac Rhythm Management Devices Market, 2010
Figure 3.5 The Global Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2021
Figure 3.6 The US Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.7 The European Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.8 The Asian Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.9 The US Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 3.10 The European Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 3.11 The Asian Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 4.1 Market Share (%) of Leading Companies in the Defibrillator Market, 2010
Figure 4.2 Sales ($bn) of Leading Companies in the Defibrillator Market, 2010
Figure 4.3 The ICD Market Share (%) by Region/Country, 2010
Figure 4.4 The ICD Market ($bn) by Region/Country, 2010
Figure 4.5 The ICD Market Forecast ($bn), 2010-2015
Figure 4.6 The ICD Market Forecast ($bn), 2015-2021
Figure 4.7 The Remote Monitoring Network for ICD Devices
Figure 5.1 Market Share (%) of Leading Companies in the Pacing Devices Market, 2010
Figure 5.2 Market Share (%) of Leading Segments in the Pacemaker Market, 2010
Figure 5.3 The Pacemaker Market ($bn) by Segment, 2010
Figure 5.4 The Pacemaker Market Share (%) by Region/Country, 2010
Figure 5.5 The Pacemaker Market ($bn) by Region/Country, 2010
Figure 5.6 The Pacemaker Market Forecast ($bn), 2010-2021
Figure 5.7 The Dual-Chamber Pacemaker Market Forecast ($bn), 2010-2015
Figure 5.8 The Dual-Chamber Pacemaker Market Forecast ($bn), 2015-2021
Figure 5.9 The Single Chamber Pacemaker Market Forecast ($bn), 2010-2021
Figure 5.10 The External Pacemaker Market Forecast ($bn), 2010-2021
Figure 6.1 Market Share (%) of Leading Segments in the Cardiac Resynchronisation Therapy Market, 2010
Figure 6.2 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2010-2015
Figure 6.3 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2015-2021
Figure 7.1 The Cardiac Ablation Market Share (%) by Region/Country, 2010
Figure 7.2 The Cardiac Ablation Market ($m) by Region/Country, 2010
Figure 7.3 The Cardiac Ablation Market Forecast ($m), 2010-2015
Figure 7.4 The Cardiac Ablation Market Forecast ($m), 2015-2021
Figure 8.1 Boston Scientific Sales Share (%) by Business Segment, 2010
Figure 8.2 Boston Scientific Sales ($bn) by Business Segment, 2010
Figure 8.3 Boston Scientific CRM Segment Sales ($m), 2009 and 2010
Figure 8.4 Boston Scientific CRM Segment US Sales ($m), 2009 and 2010
Figure 8.5 Boston Scientific CRM Segment International Sales ($m), 2009 and 2010
Figure 8.6 Medtronic Sales ($m) by Business Segment, 2009 and 2010
Figure 8.7 Medtronic Sales Share (%) by Business Segment, 2010
Figure 8.8 Medtronic CRDM Sales Share (%) 2010 by Segment, 2010
Figure 8.9 Medtronic Sales Share (%) by Region, 2010
Figure 8.10 St. Jude Medical Sales Share (%) by Business Segment, 2010
Figure 8.11 St. Jude Medical Sales Share (%) by Business Segment, 2010
Figure 8.12 St. Jude Medical CRM Segment Sales Share (%), 2010